Table 2.

Study quality assessment according to TESTEX scale.

Study	Eligibility Criteria Specified	Randomly Allocated Participants	Allocation Concealed	Groups Similar at Baseline	Assessors Blinded	Outcome Measures Assessed >85% of Participants *	Intention to Treat Analysis	Reporting of between Group Statistical Comparisons	Point Measures and Measures of Variability Reported **	Activity Monitoring in the Control Group	Relative Exercise Intensity Reviewed	Exercise Volume and Energy Expended	Overall TESTEX #
Baek et al. [28]	Yes	Yes	Unclear	Yes	Unclear	Yes (2)	Yes	Yes	Yes (2)	No	No	Yes	10/15
Campos-Mesa et al. [29]	Yes	No	Unclear	Yes	Unclear	Yes (1)	Yes	Yes	Yes (2)	Yes	No	Yes	9/15
Cho & Roh [30]	Yes	Yes	Yes	Yes	Unclear	Yes (2)	Yes	Yes	Yes (1)	No	Yes	Yes	11/15
Ciaccioni et al. [31]	Yes	No	Yes	Yes	Unclear	Yes (3)	Yes	Yes	Yes (2)	No	Yes	Yes	12/15
Combs et al. [32]	Yes	Yes	Yes	Yes	No	Yes (3)	Yes	Yes	Yes (2)	Yes	No	Yes	13/15
Cromwell et al. [33]	Yes	No	Unclear	Yes	Yes	Yes (2)	Yes	Yes	Yes (1)	No	No	Yes	9/15
Witte et al. [34]	Yes	Yes	Yes	Yes	No	Yes (3)	Yes	Yes	Yes (2)	No	No	Yes	12/15
Youm et al. [35]	Yes	Yes	Unclear	Yes	Unclear	Yes (1)	Yes	Yes	Yes (2)	No	Yes	Yes	10/15

* Three points are possible: one point if adherence >85%, one point if adverse events are reported, one point if exercise attendance is reported. ** Two points are possible: one point if the primary outcome is reported, and one point if all other outcomes are reported. # total out of 15 points. TESTEX: Tool for the assEssment of Study qualiTy and reporting in EXercise [25].